Arab Journal of Gastroenterology
Volume 10, Issue 3 , Pages 109-111 , September 2009

Gastro-oesophageal reflux disease among patients attending an endoscopic clinic in Yemen

  • Yahya Ghanem

      Affiliations

    • Internal Medicine Department (Gastroenterology), Faculty of Medicine and Health Sciences, Sana’a University, Sana’a, Yemen
    • Corresponding Author InformationCorresponding author.
    • ,
  • Nabil Ahmed Al-Rabeei

      Affiliations

    • Department of Community Health, Faculty of Medicine and Health Sciences, Sana’a University, Sana’a, Yemen
    • ,
  • Abdulsalam Dallak

      Affiliations

    • Department of Maternal and Child Health, Faculty of Medicine and Health Sciences, Sana’a University, Sana’a, Yemen

Received 1 May 2009 ,Accepted 21 May 2009.

References 

  1. Locke GR, Talley NJ, Fett S, et al. The prevalence and impact of gastroesophageal reflux disease in the United States: a population-based study. Gastroenterology. 2001;106:15–18
  2. Beck IT, Connon J, Lemire SM, et al. Canadian consensus conference on the treatment of gastroesophageal reflux disease. Can J Gastroenterol. 1992;6:277–289
  3. Revicki DA, Wood M, Maton PN, et al. The impact of gastroesophageal reflux disease on health-related quality of life. Am J Med. 1998;104(3):252–258
  4. Locke GR, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997;112(5):1448–1456
  5. Chen PH. Review: Barrett’s oesophagus in Taiwan. J Gastroenterol Hepatol. 1997;12(6):S19–S22
  6. Penston JG, Pounder RE. A survey of dyspepsia in Great Britain. Aliment Pharmacol Therap. 1996;10(1):83–89
  7. Zhang TC, Zhu MZ, Geng XC, et al. Endoscopic study of reflux oesophagitis. JAMA Southeast Asia. 2004;12:22–24
  8. Cohen S, Parkman HP. Heartburn – a serious symptom. N Engl J Med. 1999;340(11):878–879
  9. Min YI, Lee SK, Kim MH, et al. Epidemiology of reflux oesophagitis in a general health screening population. JAMA. 1999;12(2):11–15
  10. Cameron AJ, Zinsmeister AR, Ballard DJ, et al. Prevalence of columnar-lined (Barrett’s) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology. 1990;99(4):918–922
  11. Kawanishi M. Will symptomatic gastroesophageal reflux disease develop into reflux esophagitis. J Gastroenterol. 2006;41(5):440–443
  12. Kay L, Jorgensen T, Jensen KH. Epidemiology of abdominal symptoms in a random population: prevalence, incidence and natural history. Eur J Epidemiol. 1994;10(5):559–566
  13. Loss Angeles classification system, USA; 1999.
  14. Trudgill N. Familial factors and gastroesophageal reflux disease. Gastroenterology. 1997;112(4):A315
  15. Eisen GM, Sandler RS, Murray S, et al. The relationship between gastroesophageal reflux disease and its complications with Barrett’s esophagus. Am J Gastroenterol. 1997;92(1):27–31
  16. Kulig M, Nocon M, Vieth M, et al. Risk factors of gastroesophageal reflux disease methodology and first epidemiological results of the ProGERD study. J Clin Epidemiol. 2004;57(6):580–589
  17. Nebel OT, Fornes MF, Castell DO. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis. 1976;21(11):953–956
  18. Zarling EJ, Bernsen MB. The effect of gender on the rates of hospitalization for gastrointestinal illnesses. Am J Gastroenterol. 1997;92(4):621–623
  19. Chang CS, Poon SK, Lien HC, et al. The incidence of reflux esophagitis among the Chinese. Am J Gastroenterol. 1997;92(4):668–671
  20. Avidan B, Sonnenberg A, Schnell TG, et al. Risk factors for erosive reflux esophagitis: a case-control study. Am J Gastroenterol. 2001;96(1):41–46
  21. Wienback M, Barnet J. Epidemiology of reflux disease and reflux oesophagitis. Scand J Gastroenterol. 1989;24(Suppl. 156):7–13
  22. Helm MK. The tobacco health toll. World Health Organization (WHO); 2005;
  23. Edwin J. A review of RO around the world. WJG. 2001;280–282
  24. Soykan I, Lin Z, Jones S, et al. Gastric myoelectrical activity, gastric emptying and correlations with dyspepsia symptoms in patients with gastroesophageal reflux. J Invest Med. 1997;45(8):483–487
  25. Bittinger M, Messmann H. Neue endoskopische therapieverfahren bei gastroosophagealer refluxkrankheit [New endoscopic therapies for gastroesophageal reflux disease]. Z Gastroenterol. 2003;41(9):921–928
  26. Caca K. Medikamentose versus endoskopische therapie der refluxkrankheit [Drug therapy versus endoscopic surgery of esophageal reflux]. Z Gastroenterol. 2002;40(Suppl. 2):9–11
  27. Galmiche JP, Bruley des Varannes S. Endoluminal therapies for gastro-oesophageal reflux disease. Lancet. 2003;361(9363):1119–1121

PII: S1687-1979(09)00011-2

doi: 10.1016/j.ajg.2009.05.001

Arab Journal of Gastroenterology
Volume 10, Issue 3 , Pages 109-111 , September 2009

Article Tools